|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.905
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.870
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.716
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.666
|
Rat |
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.619
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.595
|
Rat |
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.566
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.554
|
Rat |
|
|
protein processing
|
GO:0016485 |
163 |
0.543
|
Rat |
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.532
|
Rat |
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.440
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.433
|
Rat |
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.423
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.402
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.398
|
Rat |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.356
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.349
|
Rat |
|
|
coagulation
|
GO:0050817 |
78 |
0.344
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.341
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.311
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.311
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.302
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.299
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.287
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.283
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.274
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.257
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.254
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.250
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.245
|
Rat |
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.236
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
10 |
0.234
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.229
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.229
|
Rat |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.223
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.221
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.220
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.215
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.212
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.212
|
Rat |
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.209
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.205
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.202
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.200
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.196
|
Rat |
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.195
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.194
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.192
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.188
|
Rat |
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.187
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.179
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.176
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.171
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.169
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.163
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.162
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.157
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.157
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.154
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.150
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.145
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.143
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.143
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.137
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.135
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.133
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.128
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.126
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.124
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.124
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.121
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.121
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.118
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.117
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.116
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.113
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.111
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.107
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.107
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.103
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.102
|
|
|
|
insulin metabolic process
|
GO:1901142 |
3 |
0.102
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.101
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.099
|
|
|
|
regulation of serine type endopeptidase activity
|
GO:1900003 |
2 |
0.098
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.098
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.095
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.094
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.093
|
Rat |
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.092
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.092
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.092
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.091
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.091
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.090
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.088
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.087
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.087
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.086
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.086
|
Rat |
|
|
gland development
|
GO:0048732 |
330 |
0.086
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.086
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.086
|
|
|
|
very long chain fatty acid catabolic process
|
GO:0042760 |
2 |
0.086
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.085
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.084
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.084
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.083
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.080
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.080
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.080
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.080
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.079
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.078
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.077
|
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.074
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.073
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.073
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.073
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.073
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.072
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.072
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.071
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.071
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.070
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.069
|
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.069
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.068
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.068
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.068
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.067
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.067
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.067
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.066
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.066
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.066
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.065
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.065
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.064
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.064
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.064
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.064
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.064
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.064
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.063
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.062
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.062
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.062
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.061
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.061
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.060
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.060
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.060
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.060
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.059
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.059
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.058
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.058
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.057
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.057
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.057
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.056
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.055
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.055
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.055
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.054
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.053
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.053
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.053
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.053
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.052
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.052
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.052
|
|
|
|
response to chromate
|
GO:0046687 |
1 |
0.052
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.052
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.051
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.051
|
Rat |
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.050
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.050
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.050
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.050
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.050
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.049
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.049
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.048
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.047
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.047
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.047
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.046
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.046
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.046
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.046
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.045
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.045
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.045
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.045
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.044
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.044
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.044
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.044
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.044
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.043
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.043
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.043
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.043
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.043
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.043
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.043
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.043
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.043
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.043
|
|
|
|
regulation of toll signaling pathway
|
GO:0008592 |
1 |
0.042
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.042
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.042
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.042
|
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.042
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.042
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.041
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
22 |
0.041
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.041
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.041
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.040
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.040
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.039
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.039
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.039
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.039
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.038
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.038
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.038
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.038
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.038
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.038
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.038
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.038
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.038
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.037
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.037
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.037
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.037
|
|
|
|
diterpenoid biosynthetic process
|
GO:0016102 |
7 |
0.037
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.037
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.037
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.037
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.036
|
Rat |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.036
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.036
|
|
|
|
negative regulation of toll signaling pathway
|
GO:0045751 |
1 |
0.036
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.036
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.035
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.035
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.035
|
|
|
|
regulation of lipoprotein metabolic process
|
GO:0050746 |
4 |
0.035
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.035
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.034
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.034
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.034
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.034
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.034
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.034
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.033
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.033
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.033
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.033
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.033
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.033
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.032
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.032
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.032
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.032
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.031
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.031
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
Rat |
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.031
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.031
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.031
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.031
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.031
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.031
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.030
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.030
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.030
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.030
|
|
|
|
heterotypic cell cell adhesion
|
GO:0034113 |
7 |
0.030
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.030
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.030
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.030
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.029
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.029
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.029
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.029
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.029
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.029
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.028
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
Rat |
|
|
sterol esterification
|
GO:0034434 |
3 |
0.028
|
|
|
|
9 cis retinoic acid biosynthetic process
|
GO:0042904 |
5 |
0.028
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.028
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.028
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.028
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.028
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.028
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.028
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.028
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.028
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.027
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.027
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.027
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.027
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.027
|
|
|
|
adiponectin activated signaling pathway
|
GO:0033211 |
4 |
0.027
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.027
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.027
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.027
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.027
|
|
|
|
heme transport
|
GO:0015886 |
2 |
0.027
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.027
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.027
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.026
|
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.026
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.026
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.026
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.026
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.026
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.026
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.026
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.026
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to iron
|
GO:0034395 |
3 |
0.026
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.026
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.026
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
protein n linked glycosylation
|
GO:0006487 |
12 |
0.026
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.026
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.025
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.025
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.025
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.025
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.025
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.025
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.025
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.025
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.025
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.025
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.025
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.025
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.025
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.025
|
|
|
|
plasminogen activation
|
GO:0031639 |
7 |
0.025
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.025
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.024
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.024
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.024
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.024
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.024
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.024
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.024
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.024
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.024
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.024
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.024
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.024
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.024
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.024
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.024
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.024
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.023
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.023
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.023
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.023
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.023
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.023
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.023
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.023
|
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.023
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.023
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.022
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.022
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.022
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.022
|
|
|
|
negative regulation of cell adhesion mediated by integrin
|
GO:0033629 |
2 |
0.022
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.022
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.022
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.022
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.022
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.022
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.022
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.022
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.022
|
|
|
|
opsonization
|
GO:0008228 |
3 |
0.022
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.022
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.022
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.022
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.021
|
|
|
|
ketone body metabolic process
|
GO:1902224 |
3 |
0.021
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.021
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.021
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.021
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.021
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
12 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.021
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.021
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.021
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.021
|
|
|
|
positive regulation of protein maturation
|
GO:1903319 |
7 |
0.021
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.020
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.020
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.020
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.020
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.020
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.020
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.020
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.019
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.019
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.019
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.019
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.019
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.019
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.019
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.019
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.019
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.019
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
low density lipoprotein particle remodeling
|
GO:0034374 |
2 |
0.019
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.019
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.019
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.019
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.019
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.018
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.018
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.018
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.018
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.018
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.018
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.018
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.018
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.018
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.018
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.018
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.018
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.018
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.018
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.018
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.018
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
|
negative regulation of lipase activity
|
GO:0060192 |
7 |
0.017
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.017
|
|